Literature DB >> 21184733

IL-13 suppresses double-stranded RNA-induced IFN-λ production in lung cells.

Atsushi Moriwaki1, Koichiro Matsumoto, Yuko Matsunaga, Satoru Fukuyama, Takafumi Matsumoto, Keiko Kan-o, Naotaka Noda, Yukari Asai, Yoichi Nakanishi, Hiromasa Inoue.   

Abstract

Acute asthma exacerbations are frequently associated with respiratory viral infections. Although impaired production of type III IFNs (IFN-λs) is related to the severity of asthma exacerbation, the mechanisms underlying deficient IFN-λ production in asthma are poorly understood. Airway epithelial cells were stimulated in vitro with a synthetic mimetic of viral double-stranded RNA (dsRNA). IL-13, a crucial cytokine responsible for asthma pathogenesis, suppressed dsRNA-induced expression of IFN-λs, and JAK inhibitor AG490 prevented the suppression by IL-13. IL-13 per se did not affect IFN-λ production or the expressions of membrane dsRNA receptor TLR3 and of cytoplasmic receptors RIG-I and MDA5. IL-13-deficient mice exhibited more enhanced IFN-λ expression after intratracheal instillation of dsRNA than wild-type mice, whereas IFN-λ expression after dsRNA was absent in the mouse lungs of the OVA-induced asthma model. These findings suggest that IL-13 may be a putative cytokine suppressing IFN-λ production against airway viral infections in asthmatics.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21184733     DOI: 10.1016/j.bbrc.2010.12.082

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  The airway epithelium in asthma.

Authors:  Bart N Lambrecht; Hamida Hammad
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 53.440

2.  Severity of virus-induced asthma symptoms is inversely related to resolution IFN-λ expression.

Authors:  Elizabeth A Schwantes; Loren C Denlinger; Michael D Evans; James E Gern; Nizar N Jarjour; Sameer K Mathur
Journal:  J Allergy Clin Immunol       Date:  2015-03-14       Impact factor: 10.793

3.  Extracellular Nucleotides and Histamine Suppress TLR3- and RIG-I-Mediated Release of Antiviral IFNs from Human Airway Epithelial Cells.

Authors:  Timothy S Kountz; Assel Biyasheva; Robert P Schleimer; Murali Prakriya
Journal:  J Immunol       Date:  2022-04-22       Impact factor: 5.426

4.  Surfactant Protein-A Protects against IL-13-Induced Inflammation in Asthma.

Authors:  Dave Francisco; Ying Wang; Michelle Conway; Audriana N Hurbon; Alane B C Dy; Kenneth J Addison; Hong W Chu; Dennis R Voelker; Julie G Ledford; Monica Kraft
Journal:  J Immunol       Date:  2020-04-03       Impact factor: 5.422

Review 5.  Interferon-λs: special immunomodulatory agents and potential therapeutic targets.

Authors:  Ya-wen Zheng; Hui Li; Jin-pu Yu; Hua Zhao; Shizhen Emily Wang; Xiu-bao Ren
Journal:  J Innate Immun       Date:  2012-11-30       Impact factor: 7.349

6.  Response of airway epithelial cells to double-stranded RNA in an allergic environment.

Authors:  Cristan Herbert; Qing-Xiang Zeng; Ramesh Shanmugasundaram; Linda Garthwaite; Brian G Oliver; Rakesh K Kumar
Journal:  Transl Respir Med       Date:  2014-09-11

Review 7.  Mast Cells and Natural Killer Cells-A Potentially Critical Interaction.

Authors:  Liliana Portales-Cervantes; Bassel Dawod; Jean S Marshall
Journal:  Viruses       Date:  2019-06-04       Impact factor: 5.048

Review 8.  Respiratory Viruses and Asthma.

Authors:  Peter A B Wark; James Michael Ramsahai; Prabuddha Pathinayake; Bilal Malik; Nathan W Bartlett
Journal:  Semin Respir Crit Care Med       Date:  2018-02-10       Impact factor: 3.119

9.  Remodeling of bronchial epithelium caused by asthmatic inflammation affects its response to rhinovirus infection.

Authors:  Bogdan Jakiela; Ana Rebane; Jerzy Soja; Stanislawa Bazan-Socha; Anet Laanesoo; Hanna Plutecka; Marcin Surmiak; Marek Sanak; Krzysztof Sladek; Grazyna Bochenek
Journal:  Sci Rep       Date:  2021-06-17       Impact factor: 4.379

Review 10.  Recent advances in understanding and managing asthma.

Authors:  Su-Ling Loo; Peter A B Wark
Journal:  F1000Res       Date:  2016-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.